Michael B. Chancellor 13D and 13G filings for Lipella Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-09 8:39 pm Purchase | 2025-04-07 | 13D | Lipella Pharmaceuticals Inc. LIPO | Michael B. Chancellor | 209,641 4.800% | 1 (+0.00%) | Filing |
| 2025-02-10 5:35 pm Unchanged | 2025-02-06 | 13D | Lipella Pharmaceuticals Inc. LIPO | Michael B. Chancellor | 209,640 7.900% | 0 (Unchanged) | Filing |
| 2025-01-30 5:28 pm Unchanged | 2025-01-28 | 13D | Lipella Pharmaceuticals Inc. LIPO | Michael B. Chancellor | 209,640 10.000% | 0 (Unchanged) | Filing |
| 2025-01-23 6:11 pm Purchase | 2025-01-21 | 13D | Lipella Pharmaceuticals Inc. LIPO | Michael B. Chancellor | 209,640 11.500% | 209,640 (New Position) | Filing |